Qiang Tai

479 total citations
45 papers, 377 citations indexed

About

Qiang Tai is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Qiang Tai has authored 45 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 15 papers in Hepatology and 13 papers in Transplantation. Recurrent topics in Qiang Tai's work include Organ Transplantation Techniques and Outcomes (24 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Liver Disease and Transplantation (9 papers). Qiang Tai is often cited by papers focused on Organ Transplantation Techniques and Outcomes (24 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Liver Disease and Transplantation (9 papers). Qiang Tai collaborates with scholars based in China and United States. Qiang Tai's co-authors include Gang Shen, Da Chen, Hongyun Jia, Ye Li, Yukun Kuang, Dawei Liu, Lin Wu, Na Liu, Linwei Wu and Anbin Hu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Carcinogenesis and Frontiers in Pharmacology.

In The Last Decade

Qiang Tai

44 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Tai China 12 143 112 94 93 54 45 377
Laura Nichols United States 9 38 0.3× 84 0.8× 35 0.4× 28 0.3× 25 0.5× 19 319
Alessandro Bersch Osvaldt Brazil 14 164 1.1× 279 2.5× 36 0.4× 89 1.0× 46 0.9× 36 541
Reyhane Ebrahimi Iran 12 193 1.3× 33 0.3× 13 0.1× 137 1.5× 96 1.8× 24 437
Masahisa Toyohara Japan 8 39 0.3× 91 0.8× 136 1.4× 37 0.4× 108 2.0× 21 344
Minjie Zhou China 10 158 1.1× 40 0.4× 12 0.1× 84 0.9× 54 1.0× 23 361
Jiansheng Xiao China 11 165 1.2× 53 0.5× 34 0.4× 55 0.6× 38 0.7× 26 313
Michał Wasilewicz Poland 11 189 1.3× 154 1.4× 187 2.0× 45 0.5× 199 3.7× 27 474

Countries citing papers authored by Qiang Tai

Since Specialization
Citations

This map shows the geographic impact of Qiang Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Tai more than expected).

Fields of papers citing papers by Qiang Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Tai. The network helps show where Qiang Tai may publish in the future.

Co-authorship network of co-authors of Qiang Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Tai. A scholar is included among the top collaborators of Qiang Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Tai. Qiang Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yang, Dandan Zhang, Mengting Wu, et al.. (2025). Spermidine supplementation protects porcine oocytes against triclosan-induced defects during maturation in vitro. Animal Reproduction Science. 282. 107999–107999.
2.
Tai, Qiang, et al.. (2025). Glucose-responsive nanozyme hydrogel for glycemic control and catalytic anti-infective therapy in diabetic wound healing. Materials Today Bio. 35. 102405–102405. 4 indexed citations
3.
Hong, Wenxin, Yan Chen, Kai You, et al.. (2020). Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study. Frontiers in Pharmacology. 11. 561674–561674. 38 indexed citations
4.
Liu, Dawei, et al.. (2020). Toll-like receptor 7 deficiency mitigates hyperoxia-induced acute lung injury in mice. Biomedicine & Pharmacotherapy. 129. 110345–110345. 4 indexed citations
5.
Chen, Zhen, Xuxia Wei, Genglong Liu, et al.. (2019). Higher vs. Lower DP for Ventilated Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Emergency Medicine International. 2019. 1–12. 8 indexed citations
6.
Liu, Dawei, et al.. (2019). Astragalin reduces lipopolysaccharide-induced acute lung injury in rats via induction of heme oxygenase-1. Archives of Pharmacal Research. 42(8). 704–711. 26 indexed citations
7.
Han, Ming, Qiang Zhao, Xiaoping Wang, et al.. (2014). Liver transplantation using organs from deceased organ donors: a single organ transplant center experience. Hepatobiliary & pancreatic diseases international. 13(4). 409–415. 9 indexed citations
8.
Zhang, Min, Yinong Ye, Jianyun Zhu, et al.. (2014). Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure. Journal of Translational Medicine. 12(1). 60–60. 15 indexed citations
9.
Zhang, Min, Yutian Chong, Qiang Tai, et al.. (2014). Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2. Journal of Translational Medicine. 12(1). 308–308. 7 indexed citations
10.
Ling, Xiaoting, et al.. (2012). Twenty-Four Hour Steroid Avoidance Immunosuppressive Regimen in Liver Transplant Recipients. Experimental and Clinical Transplantation. 10(3). 258–262. 8 indexed citations
11.
Shen, Gang, Hongyun Jia, Qiang Tai, Ye Li, & Da Chen. (2012). miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Carcinogenesis. 34(1). 211–219. 72 indexed citations
12.
Liang, Wenhua, et al.. (2012). Sirolimus Conversion in Liver Transplant Recipients With Calcineurin Inhibitor-Induced Complications: Efficacy and Safety. Experimental and Clinical Transplantation. 10(2). 132–135. 4 indexed citations
13.
Tai, Qiang, et al.. (2012). Steroid elimination within 24 hours after orthotopic liver transplantation: effectiveness and tolerability. Hepatobiliary & pancreatic diseases international. 11(2). 137–142. 5 indexed citations
14.
Wu, Linwei, Jianwei Zhang, Zhiyong Guo, et al.. (2011). Hepatic artery thrombosis after orthotopic liver transplant: a review of the same institute 5 years later.. PubMed. 9(3). 191–6. 18 indexed citations
15.
He, Xiaoshun, Linwei Wu, Zhiyong Guo, et al.. (2011). Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection. 32(6). 343–346. 2 indexed citations
16.
Ju, Wei, et al.. (2011). [Analysis on treatment outcomes in five patients with combined en bloc liver and pancreas transplantation].. PubMed. 14(5). 343–6. 1 indexed citations
17.
Wu, Linwei, Jianwei Zhang, Zhiyong Guo, et al.. (2011). Diagnosis and treatment of acute appendicitis after orthotopic liver transplant in adults.. PubMed. 9(2). 113–7. 8 indexed citations
18.
Wu, Linwei, Xiaoshun He, Weiqiang Ju, et al.. (2010). Hepatic artery thrombosis after liver transplantation. Zhonghua putong waike zazhi. 25(2). 95–97. 1 indexed citations
19.
Wang, Dongping, et al.. (2010). Sirolimus conversion in liver transplant recipients with calcineurin inhibitor-related renal insufficiency after liver transplantation. Zhonghua gan-dan waike zazhi. 16(2). 112–114. 1 indexed citations
20.
Guo, Zhiyong, Xiaoshun He, Linwei Wu, et al.. (2009). Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surgery Today. 40(1). 38–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026